Gosebruch Henry O 4
4 · Neumora Therapeutics, Inc. · Filed Sep 19, 2023
Insider Transaction Report
Form 4
Gosebruch Henry O
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2023-09-19$12.62/sh+15,000$189,371→ 15,000 total(indirect: See Footnote)
Holdings
- 382,345
Common Stock
- 127,448(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.465 to $12.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- [F2]Shares held by HG4KYC TRUST, of which Reporting Person is trustee.
- [F3]Shares held by Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust, of which Reporting Person is trustee.